Opendata, web and dolomites

BARCODED-CELLTRACING SIGNED

Endogenous barcoding for in vivo fate mapping of lineage development in the blood and immune system

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BARCODED-CELLTRACING project word cloud

Explore the words cloud of the BARCODED-CELLTRACING project. It provides you a very rough idea of what is the project "BARCODED-CELLTRACING" about.

developmental    structure    nodes    tags    hematopoietic    transplantation    progenitor    recombinase    lineage    hsc    uncovered    inability    mice    resolve    tissue    recombination    mapping    locus    cre    single    stem    diverse    fluorescent    experimental    largely    manipulations    analytical    ensemble    termed    differences    tested    blood    limited    marker    designed    hundred    fates    principles    invasive    situ    realize    builds    disruptive    output    cell    driver    vivo    polylox    fact    dissection    post    routes    hematopoiesis    generate    lineages    resolution    cells    until    genetic    endogenous    experiments    manner    mouse    mutants    marked    opposed    thousand    loxp    peripheral    answers    deconvolution    isolation    artificial    map    analyze    physiological    feasibilities    ultimately    link    relationships    questions    progeny    barcoding    power    rested    dna    inducible    chose    fate    maintains    stage    immune    zoo    notably    unperturbed    switched    traced    resolving    barcode   

Project "BARCODED-CELLTRACING" data sheet

The following table provides information about the project.

Coordinator
DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG 

Organization address
address: IM NEUENHEIMER FELD 280
city: HEIDELBERG
postcode: 69120
website: www.dkfz.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 2˙500˙000 €
 EC max contribution 2˙500˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2016-ADG
 Funding Scheme ERC-ADG
 Starting year 2017
 Duration (year-month-day) from 2017-07-01   to  2022-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG DE (HEIDELBERG) coordinator 2˙500˙000.00

Map

 Project objective

The immune system is a complex ensemble of diverse lineages. Studies on in-vivo-hematopoiesis have until now largely rested on transplantation. More physiological experiments have been limited by the inability to analyze hematopoietic stem (HSC) and progenitor cells in situ without cell isolation and other disruptive manipulations. We have developed mouse mutants in which a fluorescent marker can be switched on in HSC in situ (inducible fate mapping), and traced HSC lineage output under unperturbed conditions in vivo. These experiments uncovered marked differences comparing in situ and post-transplantation hematopoiesis. These new developments raise several important questions, notably on the developmental fates HSC realize in vivo (as opposed to their experimental potential), and on the structure (routes and nodes) of hematopoiesis from HSC to peripheral blood and immune lineages. Answers to these questions (and in fact the deconvolution of any tissue) require the development of non-invasive, high resolution barcoding systems. We have now designed, built and tested a DNA-based barcoding system, termed Polylox, that is based on an artificial recombination locus in which Cre recombinase can generate several hundred thousand genetic tags in mice. We chose the Cre-loxP system to link high resolution barcoding (i.e. the ability to barcode single cells and to fate map their progeny) to the zoo of tissue- or stage-specific, inducible Cre-driver mice. Here, I will present the principles of this endogenous barcoding system, demonstrate its experimental and analytical feasibilities and its power to resolve complex lineages. The work program addresses in a comprehensive manner major open questions on the structure of the hematopoietic system that builds and maintains the immune system. This project ultimately aims at an in depth dissection of unique or common lineage pathways emerging from HSC, and at resolving relationships within cell lineages of the immune system.

 Publications

year authors and title journal last update
List of publications.
2017 Weike Pei, Thorsten B. Feyerabend, Jens Rössler, Xi Wang, Daniel Postrach, Katrin Busch, Immanuel Rode, Kay Klapproth, Nikolaus Dietlein, Claudia Quedenau, Wei Chen, Sascha Sauer, Stephan Wolf, Thomas Höfer, Hans-Reimer Rodewald
Polylox barcoding reveals haematopoietic stem cell fates realized in vivo
published pages: 456-460, ISSN: 0028-0836, DOI: 10.1038/nature23653
Nature 548/7668 2019-04-18
2018 Thomas Höfer, Hans-Reimer Rodewald
Differentiation-based model of hematopoietic stem cell functions and lineage pathways
published pages: 1106-1113, ISSN: 0006-4971, DOI: 10.1182/blood-2018-03-791517
Blood 132/11 2019-02-12

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BARCODED-CELLTRACING" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BARCODED-CELLTRACING" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

TroyCAN (2020)

Redefining the esophageal stem cell niche – towards targeting of squamous cell carcinoma

Read More  

MuFLOART (2018)

Microbiological fluorescence observatory for antibiotic resistance tracking

Read More  

LapIt (2019)

Making AML treatment a clinical reality: A novel anti-IL7 receptor antibody to deliver Lap to 5LO positive cells

Read More